Edwards Lifesciences Current Ratio 2010-2023 | EW
Current and historical current ratio for Edwards Lifesciences (EW) from 2010 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Edwards Lifesciences current ratio for the three months ending September 30, 2023 was 3.28.
| Edwards Lifesciences Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2023-09-30 | $4.07B | $1.24B | 3.28 |
| 2023-06-30 | $3.65B | $1.16B | 3.15 |
| 2023-03-31 | $3.26B | $1.08B | 3.01 |
| 2022-12-31 | $3.10B | $1.02B | 3.03 |
| 2022-09-30 | $3.51B | $0.92B | 3.83 |
| 2022-06-30 | $3.26B | $0.97B | 3.37 |
| 2022-03-31 | $3.24B | $0.95B | 3.41 |
| 2021-12-31 | $3.18B | $1.03B | 3.08 |
| 2021-09-30 | $3.52B | $0.97B | 3.64 |
| 2021-06-30 | $3.32B | $0.89B | 3.75 |
| 2021-03-31 | $3.07B | $0.80B | 3.84 |
| 2020-12-31 | $3.09B | $0.89B | 3.46 |
| 2020-09-30 | $2.98B | $0.85B | 3.52 |
| 2020-06-30 | $2.69B | $0.87B | 3.08 |
| 2020-03-31 | $2.51B | $0.75B | 3.36 |
| 2019-12-31 | $2.98B | $0.90B | 3.31 |
| 2019-09-30 | $2.74B | $0.78B | 3.53 |
| 2019-06-30 | $2.36B | $0.70B | 3.38 |
| 2019-03-31 | $2.37B | $0.65B | 3.66 |
| 2018-12-31 | $2.29B | $0.88B | 2.61 |
| 2018-09-30 | $2.91B | $1.26B | 2.31 |
| 2018-06-30 | $2.70B | $1.45B | 1.86 |
| 2018-03-31 | $2.72B | $1.32B | 2.07 |
| 2017-12-31 | $2.55B | $1.42B | 1.80 |
| 2017-09-30 | $2.57B | $0.74B | 3.49 |
| 2017-06-30 | $2.28B | $0.56B | 4.06 |
| 2017-03-31 | $2.02B | $0.59B | 3.45 |
| 2016-12-31 | $2.24B | $0.53B | 4.21 |
| 2016-09-30 | $2.17B | $0.53B | 4.08 |
| 2016-06-30 | $1.99B | $0.48B | 4.15 |
| 2016-03-31 | $1.82B | $0.46B | 3.97 |
| 2015-12-31 | $2.05B | $0.48B | 4.30 |
| 2015-09-30 | $2.15B | $0.53B | 4.03 |
| 2015-06-30 | $2.30B | $0.45B | 5.16 |
| 2015-03-31 | $2.26B | $0.41B | 5.56 |
| 2014-12-31 | $2.23B | $0.43B | 5.24 |
| 2014-09-30 | $2.31B | $0.43B | 5.40 |
| 2014-06-30 | $2.28B | $0.54B | 4.22 |
| 2014-03-31 | $1.60B | $0.36B | 4.50 |
| 2013-12-31 | $1.73B | $0.35B | 4.99 |
| 2013-09-30 | $1.57B | $0.34B | 4.69 |
| 2013-06-30 | $1.39B | $0.31B | 4.43 |
| 2013-03-31 | $1.36B | $0.30B | 4.53 |
| 2012-12-31 | $1.29B | $0.35B | 3.72 |
| 2012-09-30 | $1.39B | $0.30B | 4.65 |
| 2012-06-30 | $1.28B | $0.28B | 4.50 |
| 2012-03-31 | $1.19B | $0.27B | 4.48 |
| 2011-12-31 | $1.17B | $0.34B | 3.49 |
| 2011-09-30 | $1.18B | $0.30B | 3.91 |
| 2011-06-30 | $1.22B | $0.31B | 3.88 |
| 2011-03-31 | $1.15B | $0.45B | 2.58 |
| 2010-12-31 | $1.03B | $0.34B | 3.06 |
| 2010-09-30 | $0.99B | $0.38B | 2.60 |
| 2010-06-30 | $0.92B | $0.25B | 3.71 |
| 2010-03-31 | $0.87B | $0.24B | 3.60 |
| 2009-12-31 | $0.89B | $0.29B | 3.06 |
| 2009-09-30 | $0.88B | $0.30B | 2.96 |
| 2009-06-30 | $0.75B | $0.25B | 3.04 |
| 2009-03-31 | $0.65B | $0.20B | 3.24 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $40.751B | $5.382B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $181.220B | 22.05 |
| Intuitive Surgical (ISRG) | United States | $109.614B | 73.26 |
| DexCom (DXCM) | United States | $42.099B | 80.71 |
| IDEXX Laboratories (IDXX) | United States | $39.278B | 48.26 |
| IQVIA Holdings (IQV) | United States | $37.465B | 22.36 |
| Alcon (ALC) | Switzerland | $35.104B | 28.82 |
| STERIS (STE) | Ireland | $19.740B | 23.93 |
| Hologic (HOLX) | United States | $17.611B | 18.20 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.183B | 0.00 |
| Waters (WAT) | United States | $15.428B | 21.80 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.508B | 14.53 |
| Sysmex ADR (SSMXY) | Japan | $10.978B | 32.31 |
| Teleflex (TFX) | United States | $10.091B | 15.72 |
| Penumbra (PEN) | United States | $9.088B | 158.02 |
| ShockWave Medical (SWAV) | United States | $6.457B | 27.26 |
| Globus Medical (GMED) | United States | $6.253B | 19.56 |
| Abcam (ABCM) | United Kingdom | $5.484B | 0.00 |
| Masimo (MASI) | United States | $5.004B | 27.53 |
| Inari Medical (NARI) | United States | $3.357B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $3.180B | 24.38 |
| Glaukos (GKOS) | United States | $3.119B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $3.025B | 12.29 |
| Integer Holdings (ITGR) | United States | $2.988B | 20.42 |
| LivaNova (LIVN) | United Kingdom | $2.524B | 17.04 |
| Pacific Biosciences Of California (PACB) | United States | $2.295B | 0.00 |
| TransMedics (TMDX) | United States | $2.280B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.179B | 18.16 |
| Veracyte (VCYT) | United States | $1.902B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.668B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.550B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.201B | 0.00 |
| OPKO Health (OPK) | United States | $1.144B | 0.00 |
| RxSight (RXST) | United States | $1.012B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.994B | 15.19 |
| Paragon 28 (FNA) | United States | $0.858B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.744B | 0.00 |
| SiBone (SIBN) | United States | $0.731B | 0.00 |
| Nevro (NVRO) | United States | $0.600B | 0.00 |
| Artivion (AORT) | United States | $0.580B | 70.60 |
| IRadimed (IRMD) | United States | $0.541B | 33.28 |
| Treace Medical Concepts (TMCI) | United States | $0.530B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.481B | 14.99 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.398B | 0.00 |
| CVRx (CVRX) | United States | $0.379B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.344B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.323B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.297B | 10.90 |
| AngioDynamics (ANGO) | United States | $0.274B | 0.00 |
| Accuray (ARAY) | United States | $0.263B | 0.00 |
| AxoGen (AXGN) | United States | $0.260B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.254B | 14.76 |
| NeuroPace (NPCE) | United States | $0.229B | 0.00 |
| 908 Devices (MASS) | United States | $0.217B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.201B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.166B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.143B | 0.00 |
| Inogen (INGN) | United States | $0.135B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.123B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.111B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.104B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.093B | 0.00 |
| Hyperfine (HYPR) | United States | $0.084B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.076B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.075B | 0.00 |
| InspireMD (NSPR) | Israel | $0.060B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.060B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.058B | 0.00 |
| Eargo (EAR) | United States | $0.054B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.053B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.052B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.044B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Neuronetics (STIM) | United States | $0.039B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.035B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.030B | 0.00 |
| PAVmed (PAVM) | United States | $0.026B | 0.00 |
| LENSAR (LNSR) | United States | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Spectral AI (MDAI) | United States | $0.018B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Envoy Medical (COCH) | United States | $0.015B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.013B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| PetVivo Holdings (PETV) | United States | $0.010B | 0.00 |
| Sientra (SIEN) | United States | $0.010B | 0.00 |
| Venus Concept (VERO) | Canada | $0.009B | 0.00 |
| Nemaura Medical (NMRD) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
| Avinger (AVGR) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
